Pandaily

Pandaily

Share this post

Pandaily
Pandaily
Chinese COVID Testing Firm Nucleus Gene in Spotlight Due to Huge Profits and Violations
Copy link
Facebook
Email
Notes
More

Chinese COVID Testing Firm Nucleus Gene in Spotlight Due to Huge Profits and Violations

Dec 05, 2022
∙ Paid

Share this post

Pandaily
Pandaily
Chinese COVID Testing Firm Nucleus Gene in Spotlight Due to Huge Profits and Violations
Copy link
Facebook
Email
Notes
More
Share
Chinese COVID Testing Firm Nucleus Gene in Spotlight Due to Huge Profits and Violations
(Source: Jiangsu Provincial Government)

The Omicron COVID-19 variant, which appears more transmissible but less pathogenic than earlier strains of the coronavirus, has caused a surge in demand for nucleic acid testing in China this year. Without test results, citizens have found themselves unable to enter certain spaces or take public transportation. How…

Keep reading with a 7-day free trial

Subscribe to Pandaily to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Pandaily
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More